MedTrace Logo

Effect of Gabapentin on Pain of the Second Cataract Surgery

NCT02127853 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2015-05-12

No results posted yet for this study

Summary

Gabapentin pretreatment may reduce hyperalgesia occurring at the second surgery in serial, bilateral cataract surgery.

Conditions

  • Hyperalgesia

Interventions

DRUG

gabapentin

100 mg tid of gabapentin is prescribed to the patient for 1 week after the first eye surgery

DRUG

placebo

the same regimen of placebo drug is prescribed to the patient for 1 week after the first eye surgery

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02127853 on ClinicalTrials.gov